Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Zylicz

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Pharmacology and Therapeutics|September 1, 1993
Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjectsM L Huang, A Van Peer, R Woestenborghs, et al.
Anticancer Research|July 1, 1989
Studies on retinotoxic potential of a novel antitumor antibiotic--sparsomycin--in ratsZ Zylicz, W J De Grip, D J Wagener, et al.
Cancer Letters|July 1, 1986
In vivo potentiation of cis-diamminedichloroplatinum (II) antitumor activity by pretreatment with sparsomycinZ Zylicz, D J Wagener, H van Rennes, et al.
Journal of the National Cancer Institute|April 1, 1987
In vitro modulation of cisplatin cytotoxicity by sparsomycin inhibition of protein synthesisZ Zylicz, D J Wagener, H van Rennes, et al.
Journal of Medicinal Chemistry|August 1, 1989
Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship studyL A van den Broek, E Lázaro, Z Zylicz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics and toxicology of sparsomycin in beagle dogsZ Zylicz, D J Wagener, P Fernandez del Moral, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Pharmacology and Therapeutics|September 1, 1993
Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjectsM L Huang, A Van Peer, R Woestenborghs, et al.
Anticancer Research|July 1, 1989
Studies on retinotoxic potential of a novel antitumor antibiotic--sparsomycin--in ratsZ Zylicz, W J De Grip, D J Wagener, et al.
Cancer Letters|July 1, 1986
In vivo potentiation of cis-diamminedichloroplatinum (II) antitumor activity by pretreatment with sparsomycinZ Zylicz, D J Wagener, H van Rennes, et al.
Journal of the National Cancer Institute|April 1, 1987
In vitro modulation of cisplatin cytotoxicity by sparsomycin inhibition of protein synthesisZ Zylicz, D J Wagener, H van Rennes, et al.
Journal of Medicinal Chemistry|August 1, 1989
Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship studyL A van den Broek, E Lázaro, Z Zylicz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics and toxicology of sparsomycin in beagle dogsZ Zylicz, D J Wagener, P Fernandez del Moral, et al.
Pageof 3